Serotypes	Serotype	NNS	B-NP	O		0	9
of	of	IN	B-PP	O		10	12
Vibrio parahaemolyticus	Vibrio_parahaemolyticus	NNP	B-NP	O		13	36
from	from	IN	B-PP	O		37	41
clinical	clinical	JJ	B-NP	O		42	50
and	and	CC	I-NP	O		51	54
environmental	environmental	JJ	I-NP	O		55	68
sources	source	NNS	I-NP	O		69	76
in	in	IN	B-PP	O		77	79
Togo	Togo	NNP	B-NP	O		80	84
(	(	(	O	O		85	86
West Africa	West_Africa	NNP	B-NP	O		86	97
)	)	)	O	O		97	98
.	.	.	O	O		98	99

Serological	Serological	JJ	B-NP	O		100	111
analysis	analysis	NN	I-NP	O		112	120
of	of	IN	B-PP	O		121	123
O	O	NN	B-NP	O		124	125
and	and	CC	I-NP	O		126	129
K	K	NN	I-NP	B-protein		130	131
antigens	antigen	NNS	I-NP	I-protein		132	140
was	be	VBD	B-VP	O		141	144
performed	perform	VBN	I-VP	O		145	154
on	on	IN	B-PP	O		155	157
343	343	CD	B-NP	O		158	161
strains	strain	NNS	I-NP	O		162	169
of	of	IN	B-PP	O		170	172
Vibro	Vibro	NN	B-NP	O		173	178
parahaemolyticus	parahaemolyticus	NN	I-NP	O		179	195
isolated	isolate	VBN	B-VP	O		196	204
from	from	IN	B-PP	O		205	209
clinical	clinical	JJ	B-NP	O		210	218
and	and	CC	I-NP	O		219	222
environmental	environmental	JJ	I-NP	O		223	236
sources	source	NNS	I-NP	O		237	244
in	in	IN	B-PP	O		245	247
Togo	Togo	NNP	B-NP	O		248	252
.	.	.	O	O		252	253

Only	Only	RB	B-NP	O		254	258
two	two	CD	I-NP	O		259	262
strains	strain	NNS	I-NP	O		263	270
were	be	VBD	B-VP	O		271	275
not	not	RB	O	O		276	279
typable	typable	JJ	B-ADJP	O		280	287
by	by	IN	B-PP	O		288	290
the	the	DT	B-NP	O		291	294
available	available	JJ	I-NP	O		295	304
O	O	NN	I-NP	O		305	306
antisera	antiserum	NNS	I-NP	O		307	315
.	.	.	O	O		315	316

K	K	NN	B-NP	O		317	318
untypable	untypable	JJ	I-NP	O		319	328
strains	strain	NNS	I-NP	O		329	336
were	be	VBD	B-VP	O		337	341
found	find	VBN	I-VP	O		342	347
in	in	IN	B-PP	O		348	350
4.8	4.8	CD	B-NP	O		351	354
%	%	NN	I-NP	O		354	355
of	of	IN	B-PP	O		356	358
isolates	isolate	NNS	B-NP	O		359	367
from	from	IN	B-PP	O		368	372
gastroenteritis	gastroenteritis	NN	B-NP	O		373	388
patients	patient	NNS	I-NP	O		389	397
,	,	,	O	O		397	398
in	in	IN	B-PP	O		399	401
11%	11%	NN	B-NP	O		402	405
from	from	IN	B-PP	O		406	410
healthy	healthy	JJ	B-NP	O		411	418
carriers	carrier	NNS	I-NP	O		419	427
,	,	,	O	O		427	428
and	and	CC	O	O		429	432
in	in	IN	B-PP	O		433	435
47%	47%	CD	B-NP	O		436	439
and	and	CC	I-NP	O		440	443
46%	46%	CD	I-NP	O		444	447
of	of	IN	B-PP	O		448	450
isolates	isolate	NNS	B-NP	O		451	459
,	,	,	O	O		459	460
respectively	respectively	RB	B-ADVP	O		461	473
,	,	,	O	O		473	474
from	from	IN	B-PP	O		475	479
water	water	NN	B-NP	O		480	485
and	and	CC	I-NP	O		486	489
fish	fish	NN	I-NP	O		490	494
samples	sample	NNS	I-NP	O		495	502
.	.	.	O	O		502	503

Thirteen	Thirteen	CD	B-NP	O		504	512
serotypes	serotype	NNS	I-NP	O		513	522
identified	identify	VBN	B-VP	O		523	533
in	in	IN	B-PP	O		534	536
Togo	Togo	NNP	B-NP	O		537	541
are	be	VBP	B-VP	O		542	545
not	not	RB	I-VP	O		546	549
considered	consider	VBN	I-VP	O		550	560
in	in	IN	B-PP	O		561	563
the	the	DT	B-NP	O		564	567
Japanese	Japanese	JJ	I-NP	B-protein		568	576
antigenic	antigenic	JJ	I-NP	I-protein		577	586
scheme	scheme	NN	I-NP	I-protein		587	593
.	.	.	O	O		593	594

The	The	DT	B-NP	O		595	598
suitability	suitability	NN	I-NP	O		599	610
of	of	IN	B-PP	O		611	613
the	the	DT	B-NP	O		614	617
Japanese	Japanese	JJ	I-NP	O		618	626
typing	typing	NN	I-NP	O		627	633
scheme	scheme	NN	I-NP	O		634	640
for	for	IN	B-PP	O		641	644
geographic	geographic	JJ	B-NP	O		645	655
areas	area	NNS	I-NP	O		656	661
outside	outside	JJ	B-ADJP	O		662	669
of	of	IN	B-PP	O		670	672
Japan	Japan	NNP	B-NP	O		673	678
is	be	VBZ	B-VP	O		679	681
discussed	discuss	VBN	I-VP	O		682	691
and	and	CC	O	O		692	695
its	its	PRP$	B-NP	O		696	699
extension	extension	NN	I-NP	O		700	709
is	be	VBZ	B-VP	O		710	712
suggested	suggest	VBN	I-VP	O		713	722
.	.	.	O	O		722	723

